Merck & Co. Inc. buy melinda
Start price
20.10.17
/
50%
€57.58
Target price
20.04.18
€59.53
Performance (%)
-6.62%
End price
20.04.18
€52.90
Summary
This prediction ended on 20.04.18 with a price of €52.90. With a performance of -6.62%, the BUY prediction for Merck & Co. Inc. by melinda closed slightly in the red. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Merck & Co. Inc. | 0.868% | 0.868% | 18.089% | 76.408% |
iShares Core DAX® | -0.612% | 0.567% | 12.585% | 14.838% |
iShares Nasdaq 100 | -3.018% | -3.205% | 26.208% | 38.328% |
iShares Nikkei 225® | -2.647% | 0.330% | 9.482% | 5.652% |
iShares S&P 500 | -1.932% | -1.126% | 23.191% | 38.791% |
According to melinda what are the pros and cons of Merck & Co. Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Merck & Co. Inc. diskutieren
PHARMA
Merck and Company spezialisiert auf die Entwicklung unter Rezept verkauft, Herstellung und Vermarktung von therapeutischen Produkten und Impfstoffen. Der Umsatz ist Aktivität gliedern sich wie folgt: - Verkauf von pharmazeutischen Erzeugnissen (73,8%): für die Behandlung von Bluthochdruck
LYNPARZA hat das Potenzial , eine neue Behandlungsoption für Patienten mit metastasierendem HER2-negativen metastasierendem Brustkrebs bieten
(Laufzeit überschritten)
Stopped prediction by melinda for Merck & Co. Inc.
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€70.76
26.10.21
26.10.21
€65.00
26.10.22
26.10.22
38.64%
27.10.22
27.10.22
Could be worthwhile Investment >10% per year
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€71.50
01.03.19
01.03.19
€77.00
04.11.21
04.11.21
-1.04%
26.10.21
26.10.21
Could be worthwhile Investment >10% per year
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€63.84
20.10.17
20.10.17
€66.00
20.04.18
20.04.18
-6.62%
20.04.18
20.04.18
Could be worthwhile Investment >10% per year
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€56.64
21.07.17
21.07.17
€59.53
14.09.17
14.09.17
5.90%
14.09.17
14.09.17
Could be worthwhile Investment >10% per year
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€62.79
21.07.17
21.07.17
€66.00
14.09.17
14.09.17
5.90%
14.09.17
14.09.17
Could be worthwhile Investment >10% per year